Regulation of Hepatocyte Nuclear Factor 4α Attenuated Lipotoxicity but Increased Bile Acid Toxicity in Non-Alcoholic Fatty Liver Disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Roh, Yoon Jin | - |
dc.contributor.author | Kim, Yun | - |
dc.contributor.author | Lee, Jae Sun | - |
dc.contributor.author | Oh, Ju Hee | - |
dc.contributor.author | Lee, Seung Min | - |
dc.contributor.author | Yoon, Eileen Laurel | - |
dc.contributor.author | Lee, Sung Ryol | - |
dc.contributor.author | Jun, Dae Won | - |
dc.date.accessioned | 2022-12-20T05:13:39Z | - |
dc.date.available | 2022-12-20T05:13:39Z | - |
dc.date.created | 2022-12-05 | - |
dc.date.issued | 2022-11 | - |
dc.identifier.issn | 2075-1729 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/172903 | - |
dc.description.abstract | <jats:p>Hepatocyte nuclear factor 4 alpha (HNF4α) is a key master transcriptional factor for hepatic fat and bile acid metabolic pathways. We aimed to investigate the role of HNF4α in non-alcoholic fatty liver disease (NAFLD). The role of HNF4α was evaluated in free fatty acid–induced lipotoxicity and chenodeoxycholic acid (CDCA)-induced bile acid toxicity. Furthermore, the role of HNF4α was evaluated in a methionine choline deficiency (MCD)-diet-induced NAFLD model. The overexpression of HNF4α reduced intracellular lipid contents and attenuated palmitic acid (PA)-induced lipotoxicity. However, the protective effects of HNF4α were reversed when CDCA was used in a co-treatment with PA. HNF4α knockdown recovered cell death from bile acid toxicity. The inhibition of HNF4α decreased intrahepatic inflammation and the NAFLD activity score in the MCD model. Hepatic HNF4α inhibition can attenuate bile acid toxicity and be more effective as a therapeutic strategy in NAFLD patients; however, it is necessary to study the optimal timing of HNF4α inhibition. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | MDPI AG | - |
dc.title | Regulation of Hepatocyte Nuclear Factor 4α Attenuated Lipotoxicity but Increased Bile Acid Toxicity in Non-Alcoholic Fatty Liver Disease | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Yoon, Eileen Laurel | - |
dc.identifier.doi | 10.3390/life12111682 | - |
dc.identifier.scopusid | 2-s2.0-85141679949 | - |
dc.identifier.wosid | 000881327500001 | - |
dc.identifier.bibliographicCitation | Life, v.12, no.11, pp.1 - 12 | - |
dc.relation.isPartOf | Life | - |
dc.citation.title | Life | - |
dc.citation.volume | 12 | - |
dc.citation.number | 11 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 12 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Life Sciences & Biomedicine - Other Topics | - |
dc.relation.journalResearchArea | Microbiology | - |
dc.relation.journalWebOfScienceCategory | Biology | - |
dc.relation.journalWebOfScienceCategory | Microbiology | - |
dc.subject.keywordPlus | RESPONSIVE ELEMENT | - |
dc.subject.keywordPlus | GENE-EXPRESSION | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | PATHWAYS | - |
dc.subject.keywordPlus | INJURY | - |
dc.subject.keywordAuthor | hepatocyte nuclear factor 4 alpha | - |
dc.subject.keywordAuthor | non-alcoholic fatty liver disease | - |
dc.subject.keywordAuthor | lipotoxicity | - |
dc.subject.keywordAuthor | bile acid toxicity | - |
dc.subject.keywordAuthor | steatohepatitis | - |
dc.identifier.url | https://www.mdpi.com/2075-1729/12/11/1682 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.